Cancer R&D 2020 Symposium
ITI is proud to be participating in the 5th International Conference on Cancer Research and Drug Development 2020, a three-day symposium bringing cutting edge developments in cancer research.
About Cancer Research & Drug Development Conference 2020
International Conference on Cancer Research and Drug Development 2019 concluded in Baltimore in Oct 21-23,2019. As promised, we gathered 135 attendees at this Cancer Conference. We are happy to share that all the cancer conference attendees, speakers and students were very much impressed with the quality of science presented at this cancer meeting. Cancer conferences by United Scientific group are launched in 2016 at Baltimore. USG’s Cancer Conference was at first launched in 2016, with an excellent organizing committee from various institutes. Cancer R&D conference 2019 had 150 attendees and we are glad to share that 26 speakers are from NCI/NIH and many more from University of Maryland and JHU. Having 150 speakers every year at our cancer conference from 17 different countries we are launching our next edition in Baltimore, MD. United Scientific Group (A Non-Profit Organization) hosted four Cancer Conferences with a title “Cancer Research and Targeted Therapy” thrice in USA and once in UK. Having a total of 200 participants and their positive notes we are happy to announce our next Cancer Conference “Fifth International Conference on Cancer Research and Drug Development 2020”. Honored with a set of eminent speakers Dr. Andrew Schally Nobel Laureate 1977, Dr. Polly Matzinger, Dr. Thomas Waldmann, Dr. Danny Welch, Dr. Leslie Costello, Dr. Suresh Ambudkar, Dr. Ying Xu, Dr. Michael Gottesman and Dr. Carolyn Compton and many more speakers worldwide. We are happy to welcome you to join the three-day cancer conference with your recent developments in the cancer research. Here we are to promise again to gather interesting talks from all over the world at Cancer R&D-2020 conference.
